OYST
OYSTER POINT PHARMA INC
$11.17
Earnings Summary
Revenue | $5.59Mn |
Net Profits | $-36.75Mn |
Net Profit Margins | -657.25% |
Highlights
OYSTER POINT PHARMA INC’s revenue fell -68.84% since last year same period to $5.59Mn in the Q3 2022. On a quarterly growth basis, OYSTER POINT PHARMA INC has generated 19.13% jump in its revenue since last 3-months.
OYSTER POINT PHARMA INC’s net profit fell -107.96% since last year same period to $-36.75Mn in the Q3 2022. On a quarterly growth basis, OYSTER POINT PHARMA INC has generated 26.42% jump in its net profits since last 3-months.
OYSTER POINT PHARMA INC’s net profit margin fell -567.41% since last year same period to -657.25% in the Q3 2022. On a quarterly growth basis, OYSTER POINT PHARMA INC has generated 38.24% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the OYSTER POINT PHARMA INC post its latest quarter earnings
EPS Estimate Current Quarter | -1.27 |
EPS Estimate Current Year | -1.27 |
Highlights
OYSTER POINT PHARMA INC’s earning per share (EPS) estimates for the current quarter stand at -1.27 - a 16.99% jump from last quarter’s estimates.
OYSTER POINT PHARMA INC’s earning per share (EPS) estimates for the current year stand at -1.27.
Key Ratios
Key ratios of the OYSTER POINT PHARMA INC post its Q3 2022 earnings
Earning Per Share (EPS) | -1.37 |
Highlights
OYSTER POINT PHARMA INC’s earning per share (EPS) fell -101.47% since last year same period to -1.37 in the Q3 2022. This indicates that the OYSTER POINT PHARMA INC has generated -101.47% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-11-10 | -1.53 | -1.37 | 10.46% |
2022-05-05 | -1.74 | -1.8 | -3.45% |
2022-08-11 | -1.66 | -1.87 | -12.65% |
₹0 US Stocks a/c Opening Fee